Abstract
Hepatocellular carcinoma is a malignant tumor responsible for approximately 600,000-700,000 deaths worldwide, and is becoming more prevalent not only in South-East Asia and Africa, but also in Western countries; therefore, interest in hepatocellular carcinoma has mounted in recent years in the West, where little or no interest was evident 10-20 years ago.
Copyright (c) 2010 S. Karger AG, Basel.
MeSH terms
-
Antineoplastic Agents / therapeutic use
-
Benzenesulfonates / therapeutic use
-
Carcinoma, Hepatocellular / diagnosis
-
Carcinoma, Hepatocellular / prevention & control*
-
Carcinoma, Hepatocellular / virology
-
Hepacivirus / pathogenicity
-
Hepatitis B virus / pathogenicity
-
Humans
-
Liver Neoplasms / diagnosis
-
Liver Neoplasms / prevention & control*
-
Liver Neoplasms / virology
-
Niacinamide / analogs & derivatives
-
Phenylurea Compounds
-
Pyridines / therapeutic use
-
Sorafenib
Substances
-
Antineoplastic Agents
-
Benzenesulfonates
-
Phenylurea Compounds
-
Pyridines
-
Niacinamide
-
Sorafenib